CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Goldman Sachs Adjusts Price Target on Viatris to $18 From $17, Maintains Neutral Rating

Neutral
AI Analysis

Summary

Goldman Sachs adjusted its price target on Viatris to $18 from $17 while maintaining a Neutral rating.

Importance:2/10
Sentiment:
0.00
analyst_callprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 22, 2026 2:31 PM

Read Original